Parkinson's Disease Care Plan Essay

Parkinson's Disease has caused problems for many people in this world and plagued the elderly all over the world.Parkinson's disease still puzzles doctors and the causes are unknown. It is known that it is a non-communicable disease and may even be hereditary. Parkinson's disease is thought to be caused by external factors.

Each year more than 60,000 Americans are diagnosed with Parkinson’s disease (PDF, 2014). That sixty thousand does not include the many thousand cases that go undetected each year. Parkinson’s is a progressive disorder that occurs in the nervous system. This disease affects a person’s movement. Parkinson’s disease develops progressively. The most common first sign of Parkinson’s is slight shaking of a body part. In the initial phase of Parkinson’s a person will experience slurring of speech and an expressionless face (Mayo Clinic, 2014). With time, the symptoms of Parkinson’s exacerbate. This disease is most frequently seen in people over the age of 50 (PDF, 2014). Parkinson’s disease is generated by a great number of reasons.

The cause of Parkinson disease, defined by Robert Hauser, who is an author of Medscape, is still unclear. Studies state that there is a combination of environmental and genetic factors for this particular disease. Approximately 10% of cases are currently genetic causes of Parkinson disease. Environmental risk factors such as use of pesticides, living in a rural environment, consumption of well water, exposure to herbicides, and proximity to industrial plants or quarries are commonly associated with the development of Parkinson disease (Hauser, 2016). In addition, according to Hauser, “genetic factors in Parkinson disease appear to be very important when the disease begins at or before age 50 years. In a study of 193 twins, overall concordance for MZ and DZ pairs was similar, but in 16 pairs of twins, in whom Parkinson disease was diagnosed at or before age 50 years, all 4 MZ pairs, but only 2 of 12 DZ pairs, was concordant.The identification of a few families with familial Parkinson disease sparked further interest in the genetics of the disease.

The main symptoms and signs of Parkinson’s are bradykinesia, rigidity and rest tremor. Parkinson’s is mainly seen as a movement disorder, but other areas of health problems are associated with it. These include depression and dementia along with autonomic disturbances and pain, although considered to be rare they can present at a later stage of the condition. These rarer symptoms, as they progress, can lead to substantial disability and handicap which harms quality of life for the person living with Parkinson’s, this also has an impact on families and carer’s.

The article “Living with Parkinson’s and Looking for Relief”, written by Carla Gantz, was found in RDH magazine as a feature in the February 2013 volume on pages 34,36,38, and 95. It is about a dental hygienist, Carla Gantz, who develops Parkinson’s disease while still in practice, and the various ways she copes with the disease. Gantz had Parkinson’s disease that was only on her right side, hand, arm, and shoulder, classifying her as stage 1 Parkinson’s disease. She started off taking low doses of levodopa to help with her tremors, but as the disease progressed, the medications changed, and the doses increased. Her role as a dental hygienist was also affected as her disease progressed. She couldn’t administer local anesthesia, her manual dexterity with instruments became more difficult, and when polishing or scaling, her hand would come to a halt, a secondary motor symptom of Parkinson’s disease. She should break this “freeze” by allowing her left arm to lift up her right arm, but that only worked for so long. Five years after being diagnosed, Gantz had to give up her career because her tremors got worse and her medication increased; she was taking up to thirteen pills per day.

While attending the Parkinson’s Support Group, I observed and took note of many occurrences throughout the group. There were 18 caregivers/individuals with Parkinson’s in attendance, along with 3 students, the director, and the group leader (a counseling student intern). Each individual diagnosed with Parkinson’s, except for two, was accompanied by their spouse/caregiver. Members of this group sat around a rectangle table with the group leader at the front. The purpose of the group, on that particular day, was to discuss challenges that individuals with Parkinson’s and or caregivers face, activities and ways to cope, and some positive gains after the disability. The type of group that was ran was a support group, as compared to having guest speakers as usual. The Parkinson’s group was open to the

Parkinson disease (PD), also referred to as Parkinson’s disease and paralysis agitans, is a progressive neurodegenerative disease that is the third most common neurologic disorder of older adults. It is a debilitating disease affecting motor ability and is characterized by four cardinal symptoms: tremor rigidity, bradykinesia or kinesis (slow movement/no movement), and postural instability. Most people have primary, or idiopathic, disease. A few patients have secondary parkinsonian symptoms from conditions such as brain tumors and certain anti-psychotic drugs.

At the same time, Parkinson’s is still quite sporadic in nature. Should there be a familial relation however, mutations in specific genes have been conclusively shown to cause Parkinson’s disease. Familial cases of Parkinson disease can be caused by mutations in the LRRK2, PARK2, PARK7, PINK1, or SNCA gene, or by alterations in genes that have not been identified. In most cases, people with these mutations will develop Parkinson’s

In a concise article, registered pharmacist Thomas Viola presents a description of the effects of Parkinson's Disease on one of his patients. Viola discusses etiology of Parkinson's Disease, progression of the disease, and pharmacological treatment. At the heart of his presentation are specific suggestions for dental professionals working with patients affected by the disease.

Parkinson’s Disease is a long-term progressive neurodegenerative disease consisting of motor system impairment, neuropsychiatric, and nonmotor features. The disease is characterized by the following key clinical features: bradykinesia, resting tremor, postural instability, and rigidity. These symptoms are due to the diminishing of dopamine in the nigrostriatal pathway and substantia nigra, which causes inhibition of the thalamus decreasing excitatory input to the motor cortex.1 Along with the key manifestations an individual with Parkinson’s Disease will experience problems associated with the disease or the antiparkinson medications. These co-occurring problems are hallucinations, dementia, daytime sleepiness, fatigue, depression, and pyschosis.2 Psychosis is a common problem in Parkinson’s Disease, and is characterized by paranoid delusions and hallucinations that are visual in nature.2 Risk factors for psychosis consists of advancing age, dementia, sleep disorders, and high doses of antiparkinson drugs.1

Parkinson’s Disease is known as one of the most common progressive and chronic neurodegenerative disorders. It belongs to a group of conditions known as movement disorders. Parkinson disease is a component of hypokinetic disorder because it causes a decreased in bodily movement. It affects people who are usually over the age of 50. It can impair an individual motor as well as non-motor function. Some of the primary symptoms of Parkinson’s disease are characterized by tremors or trembling in hands, legs and arms. In early symptoms the tremor can be unilateral, appearing in one side of body but progression in the disease can cause it to spread to both sides; rigidity or a resistant to movement affects most people with Parkinson’s disease,

Parkinson’s disease is a “progressive, degenerative neurological condition that affects a person’s control of their body movements. It is not contagious and not fatal. It is thought to be genetic in a very small percentage of cases.” (Better Health Channel, 2015) There are approximately 80,000 Australians living with Parkinson’s today. The average age of diagnosis is around 65 years of age, however, younger people can be diagnosed with Parkinson’s as well. This is known as Young Onset Parkinson’s which is usually due to genetics. It is quite difficult to diagnose Parkinson’s. There are no laboratory tests so it is important that the diagnosis is made by a specialist like a neurologist (Parkinsons.org.au, 2015).

Parkinson’s disease can be described as an issue within the nervous system that causes delayed and heavily impacted body motor skills. Sufferers face an intense loss of body movement; they face periods of unstoppable shaking, stiffened muscles, and delayed movement. Parkinson’s is commonly described as a physically impairing disease, but, in reality, it has the ability to have just as much impact on mental capabilities as it has on physical capabilities. Mainly, in the mental realm of impairment, Parkinson’s has a massive impact on emotional health. The disease and the manner in which the symptoms progressively worsen can be seriously detrimental to the well-being of a sufferer. Constantly dealing with the various symptoms and trying to cope

Definition: “Parkinson’s disease is a chronic, progressive disease of the nervous system characterized by the cardinal features of rigidity, bradykinesia, tremor, and postural instability” (O’Sullivan and Schmitz, 2007). The condition can develop between age group 60 and 80 years and symptoms mostly appear around 60 years of age (O’Sullivan and Schmitz, 2007).

Parkinson disease (PD) is a progressive neurodegenerative disorder characterized mainly by physical and psychological disabilities. This disorder was named after James Parkinson, an English physician who first described it as shaking palsy in 1817 (Goetz, Factr, and Weiner, 2002). Jean- Martin Charcot, who was a French neurologist, then progressed and further refined the description of the disease and identified other clinical features of PD (Goetz, Factr, and Weiner, 2002). PD involves the loss of cells that produce the neurotransmitter dopamine in a part of the brain stem called the substansia nigra, which results in several signs and symptoms (Byrd, Marks, and Starr, 2000). It is manifested clinically by tremor,